Mylan CEO blames rising cost of the EpiPen on 'opaque' industry pricing - News Summed Up

Mylan CEO blames rising cost of the EpiPen on 'opaque' industry pricing


Lawmakers from both parties repeatedly pointed out how Bresch’s salary had risen even faster than the price of the EpiPen. A protest against high drug prices is held outside the USC School of Pharmacy. “Yet another drug company, Mylan, has jacked up the price of a lifesaving product for no discernible reason,” Rep. Elijah Cummings (D-Md.) The EpiPen device automatically injects a drug called epinephrine, which reverses potentially deadly allergic reactions. Lawmakers said Wednesday that they believed the device held only about $1 worth of epinephrine.


Source: Los Angeles Times September 21, 2016 21:38 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */